BioCryst Pharmaceuticals | Bienes

Precio De Mercado
6.55
Cambio Diario
0.25 3.97%
Mensual
-7.62%
Anual
-27.14%
Q1 Expectativa
4.65




Bienes Cambio Fecha
Alnylam Pharmaceuticals USD 4.85B 285.64M 2025-09
BioCryst Pharmaceuticals USD 446.42M 10.76M 2025-09
Chugai Pharma JPY 2.47T 285.01B 2025-12
Daiichi Sankyo JPY 3.82T 252.52B 2025-12
DBV Technologies USD 110.49M 32.93M 2025-09
Enanta Pharmaceuticals USD 280.73M 20.3M 2025-09
Gilead Sciences USD 58.53B 2.81B 2025-09
GlaxoSmithKline GBP 61.12B 221M 2025-12
Glaxosmithkline GBP 82.45B 23.19B 2025-09
Incyte USD 6.96B 627.62M 2025-12
Ionis Pharmaceuticals USD 3.03B 47.96M 2025-09
Karyopharm Therapeutics USD 96.23M 8.65M 2025-09
Neurocrine Biosciences USD 4.27B 375.9M 2025-09
Novavax USD 1.18B 156.66M 2025-09
PTC Therapeutics USD 2.64B 9.54M 2025-09
Regeneron Pharmaceuticals USD 40.56B 389.3M 2025-12
Roche Holding CHF 100.7B 5.94B 2025-12
Sarepta Therapeutics USD 3.49B 186.38M 2025-09
Ultragenyx Pharmaceutical USD 1.19B 115.82M 2025-09
Vertex Pharmaceuticals USD 24.86B 825.6M 2025-09


BioCryst Pharmaceuticals Bienes - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Feb 2026.